Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease
- PMID: 27701410
- PMCID: PMC5315549
- DOI: 10.1038/tp.2016.186
Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease
Abstract
Reduced expression of brain-derived neurotrophic factor (BDNF) has a crucial role in the pathogenesis of Alzheimer's disease (AD), which is characterized with the formation of neuritic plaques consisting of amyloid-beta (Aβ) and neurofibrillary tangles composed of hyperphosphorylated tau protein. A growing body of evidence indicates a potential protective effect of BDNF against Aβ-induced neurotoxicity in AD mouse models. However, the direct therapeutic effect of BDNF supplement on tauopathy in AD remains to be established. Here, we found that the BDNF level was reduced in the serum and brain of AD patients and P301L transgenic mice (a mouse model of tauopathy). Intralateral ventricle injection of adeno-associated virus carrying the gene encoding human BDNF (AAV-BDNF) achieved stable expression of BDNF gene and restored the BDNF level in the brains of P301L mice. Restoration of the BDNF level attenuated behavioral deficits, prevented neuron loss, alleviated synaptic degeneration and reduced neuronal abnormality, but did not affect tau hyperphosphorylation level in the brains of P301L mice. Long-term expression of AAV-BDNF in the brain was well tolerated by the mice. These findings suggest that the gene delivery of BDNF is a promising treatment for tau-related neurodegeneration for AD and other neurodegenerative disorders with tauopathy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.Neurobiol Aging. 2016 Dec;48:135-142. doi: 10.1016/j.neurobiolaging.2016.08.020. Epub 2016 Aug 31. Neurobiol Aging. 2016. PMID: 27676333 Free PMC article.
-
Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.Neurobiol Dis. 2014 Nov;71:110-30. doi: 10.1016/j.nbd.2014.07.001. Epub 2014 Jul 15. Neurobiol Dis. 2014. PMID: 25046994
-
In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.Neuroscience. 2015 Oct 29;307:37-50. doi: 10.1016/j.neuroscience.2015.08.011. Epub 2015 Aug 20. Neuroscience. 2015. PMID: 26297896
-
Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.Mol Neurodegener. 2016 Jul 11;11(1):50. doi: 10.1186/s13024-016-0119-y. Mol Neurodegener. 2016. PMID: 27400746 Free PMC article. Review.
-
Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.Transl Neurodegener. 2022 Jan 28;11(1):4. doi: 10.1186/s40035-022-00279-0. Transl Neurodegener. 2022. PMID: 35090576 Free PMC article. Review.
Cited by
-
Influence of CurQfen®-curcumin on cognitive impairment: a randomized, double-blinded, placebo-controlled, 3-arm, 3-sequence comparative study.Front Dement. 2023 Sep 13;2:1222708. doi: 10.3389/frdem.2023.1222708. eCollection 2023. Front Dement. 2023. PMID: 39081970 Free PMC article.
-
The potential of gene delivery for the treatment of traumatic brain injury.J Neuroinflammation. 2024 Jul 28;21(1):183. doi: 10.1186/s12974-024-03156-x. J Neuroinflammation. 2024. PMID: 39069631 Free PMC article. Review.
-
Psilocybin for the treatment of Alzheimer's disease.Front Neurosci. 2024 Jul 10;18:1420601. doi: 10.3389/fnins.2024.1420601. eCollection 2024. Front Neurosci. 2024. PMID: 39050672 Free PMC article. Review.
-
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents.Molecules. 2024 May 3;29(9):2127. doi: 10.3390/molecules29092127. Molecules. 2024. PMID: 38731618 Free PMC article. Review.
-
Agomirs upregulating carboxypeptidase E expression rescue hippocampal neurogenesis and memory deficits in Alzheimer's disease.Transl Neurodegener. 2024 Apr 26;13(1):24. doi: 10.1186/s40035-024-00414-z. Transl Neurodegener. 2024. PMID: 38671492 Free PMC article.
References
-
- Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42: 631. - PubMed
-
- Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997; 41: 17–24. - PubMed
-
- Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010; 142: 387–397. - PubMed
-
- Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007; 316: 750–754. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical